Literature DB >> 9490699

The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene.

T B van Dijk1, E Caldenhoven, J A Raaijmakers, J W Lammers, L Koenderman, R P de Groot.   

Abstract

Eosinophil-derived neurotoxin (EDN) found in the granules of human eosinophils is a cationic ribonuclease toxin. Expression of the EDN gene (RNS2) in eosinophils is dependent on proximal promoter sequences in combination with an enhancer located in the first intron. We further define here the active region of the intron using transfections in differentiated eosinophilic HL60 cells. We show that a region containing a tandem PU.I binding site is important for intronic enhancer activity. This region binds multiple forms of transcription factor PU.I as judged by gel-shift analysis and DNA affinity precipitation. Importantly, introducing point mutations in the PU.I site drastically reduces the intronic enhancer activity, showing the importance of PU.I for expression of EDN in cells of the eosinophilic lineage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490699

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.

Authors:  A Iwama; J Pan; P Zhang; W Reith; B Mach; D G Tenen; Z Sun
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 2.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

3.  Eosinophils derived from acute promyelocytic leukemia cells after arsenic trioxide treatment.

Authors:  Kazuhito Yamamoto; Nobuhiko Emi; Tomohiro Kajiguchi; Shunji Yamamori; Yoshitaka Ono; Tomoki Naoe
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

4.  Sequence variation at two eosinophil-associated ribonuclease loci in humans.

Authors:  J Zhang; H F Rosenberg
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

5.  GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.

Authors:  Zhijun Qiu; Kimberly D Dyer; Zhihui Xie; Madeleine Rådinger; Helene F Rosenberg
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

6.  Identification of a purine-rich intronic enhancer element in the mouse eosinophil-associated ribonuclease 2 (mEar 2) gene.

Authors:  Kimberly D Dyer; Takeaki Nitto; Joanne M Moreau; Amanda L McDevitt; Helene F Rosenberg
Journal:  Mamm Genome       Date:  2004-02       Impact factor: 2.957

7.  Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

Authors:  Qi Chen; Hamid Razzaghi; F Yesim Demirci; M Ilyas Kamboh
Journal:  Atherosclerosis       Date:  2008-02-01       Impact factor: 5.162

8.  ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.

Authors:  Nina Germic; Aref Hosseini; Darko Stojkov; Kevin Oberson; Meike Claus; Charaf Benarafa; Sara Calzavarini; Anne Angelillo-Scherrer; Isabelle C Arnold; Anne Müller; Carsten Riether; Shida Yousefi; Hans-Uwe Simon
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

9.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

10.  Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma.

Authors:  Tae Gi Uhm; Byung Soo Kim; Il Yup Chung
Journal:  Allergy Asthma Immunol Res       Date:  2011-11-25       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.